The 10-second takeaway
For the quarter ended Dec. 31 (Q3), Steris met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share increased significantly.
Gross margins contracted, operating margins contracted, and net margins increased.
Steris booked revenue of $355.2 million. The six analysts polled by S&P Capital IQ expected revenue of $360.5 million on the same basis. GAAP reported sales were 8.2% higher than the prior-year quarter's $328.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.59. The seven earnings estimates compiled by S&P Capital IQ forecast $0.60 per share on the same basis. GAAP EPS of $0.58 for Q3 were 61% higher than the prior-year quarter's $0.36 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 38.9%, 290 basis points worse than the prior-year quarter. Operating margin was 15.5%, 150 basis points worse than the prior-year quarter. Net margin was 9.5%, 290 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $373.3 million. On the bottom line, the average EPS estimate is $0.61.
Next year's average estimate for revenue is $1.39 billion. The average EPS estimate is $2.19.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 89 members out of 107 rating the stock outperform, and 18 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Steris a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Steris is outperform, with an average price target of $38.
Can your retirement portfolio provide you with enough income to last? You'll need more than Steris. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Steris to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.